Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.568EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.13 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.372EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.634EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.37.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.630EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.360EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.578EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.544EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.448EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.425EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.354EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.503EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.623EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.214.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.588EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.210EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.567EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.541EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.189EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.563EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.258EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.426EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.399EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.337EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.539EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.164EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.392EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.377EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.86 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.7 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.12 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.7.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used